) is of fundamental importance for the normal function of endothelial NO synthase.
D epletion of vascular NO (
· NO) has been shown to play a fundamental role in the pathogenesis of atherosclerosis. A large body of evidence has corroborated heightened levels of superoxide (O 2 ·Ϫ) in the inactivation of · NO as a pathophysiologically relevant mechanism in vivo. 1 The sources of O 2 ·Ϫ in the vasculature are numerous and include NAD(P)Hdependent oxidases, xanthine oxidase, and the mitochondrial respiratory chain. Recently, it has been demonstrated that under limiting concentrations of tetrahydrobiopterin (BH 4 ), endothelial NO synthase (eNOS) generates O 2 ·Ϫ. [2] [3] [4] In support of a critical role for BH 4 
in mediating O 2 ·Ϫ formation
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from eNOS are the observations that reduction of BH 4 levels by inhibition of GTP cyclohydrolase I, the rate-limiting enzyme for BH 4 synthesis in cells and intact vessel segments, results in reduced · NO generation, increased generation of O 2 ·Ϫ and hydrogen peroxide, and impairment of vascular relaxation. [5] [6] [7] In addition, supplementation of cellular BH 4 increases the ability of NO synthase to generate · NO. 8 -10 These findings have led to the hypothesis that correction of BH 4 levels by supplementation with BH 4 analogues, such as sepiapterin, may represent a therapeutic strategy to ameliorate vascular function. Sepiapterin is an oxidized BH 4 analogue that generates BH 4 on 2 sequential enzymatic reductions by sepiapterin reductase and dihydrofolate reductase ( Figure 1 ). This compound has been extensively used to augment BH 4 in conditions associated with altered BH 4 metabolism, such as diabetes, atherosclerosis, ischemia/reperfusion, smoking, and hypertension. Studies in experimental animal models and humans in these conditions have demonstrated favorable effects on endothelial function with short-term (Յ60-minute) exposure to BH 4 . 7, [11] [12] [13] [14] [15] [16] It has also been hypothesized that a considerable proportion of BH 4 undergoes oxidation in conditions associated with heightened oxidative stress, contributing to further BH 4 depletion. 17 Consistent with this, it has been demonstrated in cultured endothelial cells that vitamin C, an antioxidant, stimulates NO synthase secondary to increases in BH 4 levels through its chemical stabilization. 18 -20 The implication of these findings on the in vivo stability of BH 4 in the vessel wall and its effects on endothelial function are currently unknown. Accordingly, the purpose of the present study was to investigate the effects of experimental atherosclerosis on vascular BH 4 levels and the consequences of modulating the latter with sepiapterin in the presence and absence of N-acetylcysteine (NAC), a thiol antioxidant compound.
Scheme I involves BH 4 production from sepiapterin. 7,8-Dihydrobiopterin (7, ) is the stable intermediate formed by sepiapterin reductase and/or oxidation of BH 4 .
Methods
Animal Model
Male New Zealand White rabbits (nϭ18) were used in the present study. A total of 9 rabbits were fed a standard diet of rabbit chow (normocholesterolemic [NC] rabbits), and the remaining rabbits were fed an atherogenic diet consisting of standard rabbit chow supplemented with 1.0% cholesterol (Purina Chow) for 8 to 10 weeks (hyperlipidemic [HL] rabbits). At the end of this period, blood samples for lipid profiles were determined for all rabbits. Rabbits were then euthanized with an intravenous injection of sodium pentobarbital, and tissues were harvested for investigation.
Organoid Cultures of Rabbit Aorta
After dissection of adventitial tissue, 2 aortic segments (3 mm) from each animal (NC rabbits, nϭ5; HL rabbits, nϭ5) were incubated in a 6-well plate that contained DMEM (GIBCO-BRL), antibiotics (100 U/mL penicillin and 100 mg/L streptomycin), and 0.1% calf serum. Sepiapterin was added to 1 of the segments at a final concentration of 0.1 mmol/L and was incubated for another 6 hours in a humidified incubator under an atmosphere of 5% CO 2 /95% air at 37°C. At the end of this period, a segment from each well was removed for organ chamber studies as detailed below. The other segment was snapfrozen in liquid nitrogen for determination of BH 4 levels.
Organ Chamber Studies
Aortas harvested from rabbits were placed in chilled modified Krebs-HEPES buffer (composition in mmol/L: NaCl 99. 25 .0, and glucose 11.1, pH 7.40. The solution was aerated continuously with a 95% O 2 /5% CO 2 mixture and maintained at 37°C. Care was taken not to injure the endothelium during preparation of the rings. Tension was recorded with a linear force transducer. Over a period of 1 hour, the resting tension was gradually increased, and the ring segment was frequently exposed to 80 mmol/L KCl, until the optimal tension for generating force during isometric contraction was reached. In preliminary experiments, this proved to be 3.0 g in all subsets of animals. The vessels were left at this resting tension throughout the remainder of the study. Experiments were performed in the presence of indomethacin (10 mol/L) to prevent prostaglandin synthesis. The vessels were then preconstricted with gradual doses of L-phenylephrine (0.15 mol/L). After a stable contraction plateau that approximated 40% to 50% of peak tension generated with the maximal dose of KCl was reached, the rings were exposed to the endothelium-dependent agonist acetylcholine (ACh, 1 nmol/L to 1 mol/L), the endothelium-independent vasorelaxant nitroglycerin (1 nmol/L to 10 mol/L), and the calcium ionophore A23187 (1 nmol/L to 1 mol/L). The vessels were then washed thoroughly and allowed to equilibrate for another hour before being subjected to vasoconstrictors. Vessels were allowed to equilibrate for at least 2 hours at a resting tension of 3 g before being subjected to graded doses of phenylephrine (1 nmol/L to 0.1 mmol/L). Responses were then expressed as a percentage of the peak response to 80 mmol/L KCl.
High-Performance Liquid Chromatographic Measurements of BH 4 in Aortic Segments
Measurement of BH 4 by high-performance liquid chromatography (Hewlett Packard Series 1100, Agilent Technologies) with fluorescence detection is indirect and is based on the quantification of biopterin, a highly fluorescent BH 4 analogue. Oxidation of BH 4 to biopterin under acidic conditions is quantitative. Under basic conditions, however, BH 4 is further oxidized to nonfluorescent compounds. Thus, BH 4 concentrations are calculated from the difference of biopterin measured in these conditions. Frozen aortic segments from normal and hypercholesterolemic rabbits isolated as described above were cryopulverized and divided into 2 fractions of known weight. One fraction was suspended in HCl (0.25 mL, 0.1N), and the other was suspended in NaOH (0.3 mL, 0.1N). A solution of 4% I 2 /8% KI (0.25 mL) was added to each fraction, which was kept on ice and protected from light. Each fraction was sonicated twice on a water/ice bath for 1 minute by use of 25% sonicator full-power potency to break open the cells. After a 90-minute incubation at room temperature, 50 L of a 50% ascorbate solution was added to remove excess iodine solution and then centrifuged at 14 000 rpm for 10 minutes to remove tissue debris. After adjustment of pH to 4.0 with HCl, supernatants were injected onto a Kromasil C-18 column (5 m, Alltech) equilibrated with phosphate buffer (0.15 mmol/L, pH 6.4), and biopterin was analyzed by authentic standards.
Electron Spin Resonance Measurements
Electron spin resonance spectra were recorded at room temperature on a Varian E-109 spectrometer operating at 9.5 GHz and with a 100-kHz field modulation equipped with a loop gap resonator. This device allows electron paramagnetic resonance (EPR) measurements of small sample volumes, typically Ͻ20 L. Reactions were initiated by the addition of eNOS to the incubation mixtures containing
, and HEPES buffer (50 mmol/L, pH 7.4). The EPR spectra were recorded at room temperature as previously described. 2 
Statistical Analysis
All data are expressed as meanϮSE. Comparisons across groups were made by 1-way ANOVA. For differences between paired observations, a t test was used when appropriate. When significance was detected, a post hoc Newman-Keuls multiple comparison test was performed. All statistical analyses were performed with the use of GraphPad software (version 3.02).
Results
Rabbit Plasma Cholesterol Levels
At the end of the 8-to 10-week period of 1% cholesterol administration, the average total plasma cholesterol level was 1465Ϯ333 mg/dL. The total cholesterol level in the control group was 52Ϯ17 mg/dL.
BH 4 Levels in Aortas From HL Rabbits
Figure 2 depicts BH 4 levels in aortic segments cultured in DMEM culture media for 6 hours in the presence and absence of sepiapterin. Aortic segments from control NC rabbits contained 743Ϯ264 ng BH 4 per gram tissue, whereas aortic segments from HL rabbits contained 28Ϯ14 ng BH 4 per gram tissue (PϽ0.001 versus NC by ANOVA), a 27-fold reduction in levels. Oxidized pteridine (BH 2 ) concentration (298.1Ϯ 105.8 ng per gram tissue) was found in NC tissue, which represents Ϸ30% of the total oxidized and reduced BH 4 content. In HL tissue, the BH 2 concentration was 52.5Ϯ23.6 ng per gram tissue, representing Ϸ63% of the total. In the analysis of HL tissue, the presence of other fluorescent products was evident. However, their concentration could not be determined and was not included in our calculations because their identity remains to be established. On 6 hours of incubation with sepiapterin, the BH 4 content in HL aortas increased 21-fold (to 589Ϯ97 ng BH 4 per gram tissue, PϭNS for HL group with sepiapterin [HL-Sep] versus the NC group and the NC group with sepiapterin [NC-Sep]), whereas incubation of the aortic segments from NC animals demonstrated no significant change in BH 4 content (570Ϯ91 ng BH 4 per gram tissue) compared with untreated NC segments. We also performed experiments in freshly isolated segments of aorta derived from animals fed control chow (NC group) and from animals fed hyperlipidemic chow (HL group) for a duration of 8 to 10 weeks. BH 4 levels were similarly diminished in the HL group (0.69Ϯ0.92 ng per gram tissue, nϭ4), with a 17-fold reduction compared with control aortas (11.73Ϯ4.8 ng per gram tissue, nϭ4). Endothelial denudation reduced the levels in control rabbits to those seen with hyperlipidemia (1.66 ng/mg tissue, nϭ1). Figure 3 demonstrates responses to the endothelium-dependent agonists ACh and A23187 in NC rabbits after constriction with L-phenylephrine. Incubation with sepiapterin for 6 hours failed to improve peak relaxations and ED 50 to both agonists (see Table) . In contrast to the lack of an effect of BH 4 in NC aortas, incubation of HL aortic segments with sepiapterin resulted in a pronounced impairment in responses to both agonists, as shown in Figure 3 and the Table.
Effect of Sepiapterin on Responses to ACh and A23187
Effects of Sepiapterin on Smooth Muscle Function
Nitroglycerin induced dose-dependent relaxations in preconstricted NC and HL ring segments, which did not differ with supplementation with BH 4 (see Figure 4 and Table) . Ring segments from HL aortas demonstrated a trend toward heightened peak constriction to the vasoconstrictor phenylephrine (156Ϯ2% versus 148Ϯ10% for HL and NC groups, respectively; PϭNS) and a shift in sensitivity (EC 50 6.37Ϯ0.1 and 6.23Ϯ0.03 for HL and NC groups, respectively; PϽ0.05 by ANOVA; see Table) . Responses to phenylephrine were unchanged in NC and HL aortas subjected to sepiapterin (NC-Sep and HL-Sep groups, respectively; Table) .
Effect of NAC on Endothelial Function and BH 4 Levels
In a separate set of experiments, we examined the effects of the thiol antioxidant compound NAC (1 mmol/L) in preserv- . Tissues were incubated in the presence or absence of sepiapterin in DMEM culture media containing antibiotics and 0.1% calf serum. Sepiapterin was added to 1 of the segments at a final concentration of 0.1 mmol/L and was incubated for 6 hours under an atmosphere of 5% CO 2 /95% air at 37°C. Segments were preconstricted with PE, and vascular response to cumulative doses of NTG (10 Ϫ10 to 10 Ϫ5 ) and PE (10 Ϫ10 to 10 Ϫ5 ) was examined. Figure 5 depicts peak responses to ACh and A23187. NAC did not improve responses to ACh or A23187. Interestingly, although NAC, when used in conjunction with sepiapterin, markedly increased BH 4 levels, this failed to translate into improvements in responses to ACh and A23187 (see Figure 5 ). 
Effect of Sepiapterin on · NO/O 2 ·؊ Production From eNOS
Discussion
The key findings of the present study are as follows: (1 
BH 4 Levels and Atherosclerosis
Although a number of studies have inferred alterations in BH 4 levels in atherosclerosis, none has provided direct measurements in the vessel wall. The present study demonstrates marked decreases in BH 4 in the HL model within 10 weeks of lipid feeding. The levels of reduction (Ͼ95%) were profound and were associated with marked abnormalities in agonist responsiveness to ACh and A23187. These results are consistent with prior studies involving in vitro manipulation of BH 4 levels in the aortic wall and in cultured cells with 2,4-diamino-6-hydroxypyrimidine, an inhibitor of BH 4 biosynthesis, demonstrating that substantial depletion of BH 4 is required before there are reductions in · NO production. 7, 21 Recently, a genetic model of GTP cyclohydrolase I deficiency has been described, characterized by Ϸ60% reduction in vascular BH 4 levels. Interestingly, the animals did not exhibit differences in baseline agonist responsiveness compared with their wild counterparts. However, they demonstrated decreases in eNOS activity with a corresponding increase in reactive oxygen species that was attributable to uncoupled NO synthase, which was corrected by shortterm exposure to BH 4 . At first glance, these results could be attributed to the in vitro culture system used in the study, because it is certainly possible that culturing diseased vessel segments from animals that have alterations in free radical defense systems may confer a selective vulnerability to oxidant stress that is not seen in control vessels. Therefore, we performed additional experiments in which we measured BH 4 levels in freshly isolated segments. The results confirmed the fact that HL vessels had BH 4 levels that were 15-to 30-fold lower than the levels in control animals. These results reiterate prior observations that cell culture conditions do not have an impact on BH 4 levels over the short term (Ͻ24 hours) in intact preparations. 22 In the present study, supplementation of aortas with sepiapterin in NC animals for 6 hours did not increase BH 4 levels compared with the levels in nonsupplemented aortas in NC animals, whereas it restored levels to near normal in atherosclerotic vessels and, in combination with NAC, led to further increases beyond those in NC aortas. There are a variety of potential explanations for these findings. BH 4 depletion in HL aortas could occur secondary to impairment in BH 4 synthesis, increased BH 4 oxidation, and/or diminished BH 4 recycling (see scheme I). The finding that levels increased only under conditions of BH 4 depletion but not under control conditions suggests that there are indeed mechanisms regulating optimal BH 4 concentrations in the vessel wall. The observation that one is able to further potentiate levels with NAC in the presence of sepiapterin in hyperlipidemia suggests disruption in the mechanisms maintaining optimal intracellular BH 4 concentrations.
Sepiapterin and Endothelium-Dependent Responses in Atherosclerosis
In spite of restoration of BH 4 levels, sepiapterin paradoxically worsened responses to ACh and A23187. Recent in vitro studies demonstrated that 77,8-BH 2 enhances O 2 ·Ϫ generation by uncoupling NADPH from L-arginine oxidation by eNOS. 22 This effect is also observed with BH 4 -replete eNOS, demonstrating that sepiapterin in high concentrations enhances O 2 ·Ϫ generation from eNOS. In aortas derived from HL animals, it is likely that sepiapterin itself and/or the accumulation of 7,8-BH 2 produced from sepiapterin reduction (see scheme I) enhances O 2 ·Ϫ production from eNOS, thereby further impairing vasorelaxation. Smooth muscle function was unimpaired, as evidenced by preserved responses to the · NO donor nitroglycerin and the vasoconstrictor phenylephrine, ruling out direct toxic effects on the smooth muscle or on the guanylate cyclase-cGMP pathway, mediated by sepiapterin. In agreement with the present study, previous experiments in canine and human internal mammary artery segments have demonstrated worsening of responses to the endothelium-dependent agonist A23187 after 24 hours of exposure to sepiapterin in organoid cultures. 22, 23 There are several important differences between this and other studies that have demonstrated an improvement in endotheliumdependent relaxation with BH 4 or its analogue sepiapterin. First, the duration of exposure in the present study was much longer than that in studies that have demonstrated an improvement (6 hours versus Յ60 minutes in the present study). [11] [12] [13] 24, 25 Second, most studies that have demonstrated an improvement in agonist responses have been short-term incubations or infusions with BH 4 rather than its precursor sepiapterin. 13, 24, 25 The possibility of BH 4 acting as an antioxidant in these studies cannot be ruled out. In this regard, we have recently determined the rate constant for the reaction between BH 4 and O 2 ·Ϫ to be Ϸ10 5 mol/L per second, which is close to the reported rate constant for ascorbate with O 2 ·Ϫ. 26, 27 However, in view of the lower prevailing concentrations of BH 4 compared with the 30 to 50 mol/L concentrations of ascorbate in vivo, it is likely that BH 4 acts through mechanisms other than O 2 ·Ϫ scavenging. In studies that have used sepiapterin and that have demonstrated an improvement in vasomotor responsiveness, the exposures times to the drug have been brief, 28, 29 and these studies did not provide measurements of intracellular BH 4 levels to firmly conclude that the effects were secondary to increases in intracellular BH 4 levels.
Thiol Antioxidants as a Strategy to Rescue Cellular BH 4 Levels
Incubations with NAC, a thiol antioxidant, failed to raise BH 4 levels, whereas in the presence of sepiapterin, they resulted in marked elevations in atherosclerotic vessels. The lack of effect of NAC on BH 4 is in contrast to previous studies in endothelial cells, which have suggested that antioxidant therapy (such as with ascorbate) increases BH 4 levels. 18 -20 The lack of increase in atherosclerotic vessels with NAC alone but a marked increase in the presence of sepiapterin suggest that oxidative modification of BH 4 is not the sole mechanism involved in the lack of BH 4 . Recently, it has been suggested that depletion of GTP plays a role in BH 4 deficiency, although this possibility is unlikely. 30 Alternatively, there is experimental evidence that oxidized LDL downregulates the expression of GTP cyclohydrolase I. 31 Of note, the increase in cellular BH 4 levels with NAC in combination with sepiapterin was not paralleled by improvements in endothelial function to ACh and A23187. This result further supports the idea that BH 4 alone is not the only variable controlling · NO and O 2 ·Ϫ formation from eNOS. Even though BH 4 levels are augmented, it is the ratio between BH 4 and oxidized BH 4 metabolites such as 7,8-BH 2 that controls eNOS activity. This suggests the existence of a BH 4 concentration threshold in the control of eNOS function in vivo. Interestingly, NAC by itself did not improve responses to either ACh or A23187 in the present study. There is a variety of explanations for this finding. First, it is possible that the concentration of thiols used was insufficient to counteract ongoing oxidative stress over the 6-hour experiment. Second, it is possible that nonoxidative mechanisms control responsiveness such that antioxidants may be ineffective. Finally, the ongoing O 2 ·Ϫ formation from eNOS as a consequence of the lack of BH 4 may cause oxidative damage to eNOS, perpetuating a "dysfunctional" eNOS.
In summary, these data provide novel insights into the magnitude and mechanisms underlying BH 4 depletion in atherosclerosis, reemphasizing the critical role of the cofactor in the vasculature. Prolonged exposure to oxidized BH 4 analogues may potentially worsen endothelial function. Our observations reemphasize the need to understand pathways regulating BH 4 metabolism in hypercholesterolemia to provide a rationale for its therapeutic application.
